Critical and distinct roles of cell type-specific NF-κB2 in lung cancer
Different from the well-studied canonical NF-κB member RelA, the role of the noncanonical NF-κB member NF-κB2 in solid tumors, and lung cancer in particular, is poorly understood. Here we report that in contrast to the tumor-promoting role of RelA, NF-κB2 intrinsic to lung epithelial and tumor cells had no marked effect on lung tumorigenesis and progression. On the other hand, NF-κB2 limited dendritic cell number and activation in the lung but protected lung macrophages and drove them to promote lung cancer through controlling activation of noncanonical and canonical NF-κB, respectively. NF-κB2 was also required for B cell maintenance and T cell activation. The antitumor activity of lymphocyte NF-κB2 was dominated by the protumor function of myeloid NF-κB2; thus, NF-κB2 has an overall tumor-promoting activity. These studies reveal a cell type-dependent role for NF-κB2 in lung cancer and help understand the complexity of NF-κB action and lung cancer pathogenesis for better design of NF-κB-targeted therapy against this deadliest cancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
JCI insight - 9(2024), 4 vom: 22. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sun, Fan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cancer |
---|
Anmerkungen: |
Date Completed 23.02.2024 Date Revised 30.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1172/jci.insight.164188 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368757579 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368757579 | ||
003 | DE-627 | ||
005 | 20240331001002.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240222s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1172/jci.insight.164188 |2 doi | |
028 | 5 | 2 | |a pubmed24n1357.xml |
035 | |a (DE-627)NLM368757579 | ||
035 | |a (NLM)38385745 | ||
035 | |a (PII)e164188 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sun, Fan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Critical and distinct roles of cell type-specific NF-κB2 in lung cancer |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.02.2024 | ||
500 | |a Date Revised 30.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Different from the well-studied canonical NF-κB member RelA, the role of the noncanonical NF-κB member NF-κB2 in solid tumors, and lung cancer in particular, is poorly understood. Here we report that in contrast to the tumor-promoting role of RelA, NF-κB2 intrinsic to lung epithelial and tumor cells had no marked effect on lung tumorigenesis and progression. On the other hand, NF-κB2 limited dendritic cell number and activation in the lung but protected lung macrophages and drove them to promote lung cancer through controlling activation of noncanonical and canonical NF-κB, respectively. NF-κB2 was also required for B cell maintenance and T cell activation. The antitumor activity of lymphocyte NF-κB2 was dominated by the protumor function of myeloid NF-κB2; thus, NF-κB2 has an overall tumor-promoting activity. These studies reveal a cell type-dependent role for NF-κB2 in lung cancer and help understand the complexity of NF-κB action and lung cancer pathogenesis for better design of NF-κB-targeted therapy against this deadliest cancer | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cancer | |
650 | 4 | |a Lung cancer | |
650 | 4 | |a Oncology | |
650 | 7 | |a NF-kappa B |2 NLM | |
650 | 7 | |a NF-kappa B p52 Subunit |2 NLM | |
700 | 1 | |a Xiao, Yadong |e verfasserin |4 aut | |
700 | 1 | |a Shapiro, Steven D |e verfasserin |4 aut | |
700 | 1 | |a Qu, Zhaoxia |e verfasserin |4 aut | |
700 | 1 | |a Xiao, Gutian |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t JCI insight |d 2016 |g 9(2024), 4 vom: 22. Feb. |w (DE-627)NLM257703918 |x 2379-3708 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2024 |g number:4 |g day:22 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.1172/jci.insight.164188 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2024 |e 4 |b 22 |c 02 |